 |
|
2006 Cancer Report
Breast Cancer
- Site Cases And Comparisons for 2005
- Cancer Registry Data Summary For 2005
- 2005 Breast Cancer Study by Koteshwar Telukuntla, M.D.
Our Cancer Program
The Oncology Committee of Manatee Memorial Hospital (MMH) is pleased to present this online brief overview of our cancer program.
Dedicated to serving our cancer patients and their families, MMH offers community outreach programs that include health fairs and cancer support groups.
Summary of Cancer Registry Data for 2005
A total of 820 new cancer patients were treated at MMH during 2005. Of those, 554 were analytic cases (cases diagnosed and/or treated initially by our medical staff). The remaining 266 patients were non-analytic (diagnosed and received first-course treatment elsewhere).
Other areas reviewed by a registry include gender, race and age distributions. Our patient population demonstrates that 52% men and 48% women were diagnosed with cancer in 2005. The race distribution shows 90% were Caucasian, 7% were African-Americans and less than 3% were other races.
Age is an important factor in cancer risk and cancer care. Annual health exams should continue as we grow older. The largest age group diagnosed with cancer included persons from 70-79 years old. They represent more than 29% of our 2005 population.
Staging cancer is one of the most important components of cancer care from the physician’s viewpoint. Determining the stage of the disease, or how far it has spread in the body, helps the physician determine the type of treatment best suited to the patient.
The stages range from stage 0 to stage IV, with the higher the number, such as stage IV, indicating a more serious cancer. MMH stage distribution of analytic cases:
- Stage 0 – 9%
- Stage I – 18%
- Stage II- 16%
- Stage III – 14%
- Stage IV – 20%
- Stage Unknown – 10%
- Stage Not Applicable – 12%.
Cancer sites most frequently seen at MMH during 2005 are demonstrated below. A comparison is made with state and national statistics.
Lung cancer was our most frequent site, representing 24% of all new MMH cancer cases; the State of Florida reported 14%. The second most prominent site was breast cancer with 16% diagnosed at Manatee Memorial and 14% seen in Florida. Colorectal cancer, Non-Hodgkin’s Lymphoma and bladder cancer were the third, fourth and fifth most frequently registered sites at Manatee Memorial.
Breast Cancer Study
Reviewed by: Koteshwar Telukuntla, M.D.
Breast cancer is the most common cancer among women. Approximately 212,920 new diagnoses of invasive female breast cancer were expected to occur during 2006. According to the American Cancer Society, more than two million women living in the United States have been treated for breast cancer. The chance of a woman developing invasive breast cancer is approximately 1 in 8. The chance of dying from breast cancer is about 1 in 33. The good news is that breast cancer death rates are going down. This decline is believed to be the result of finding breast cancer earlier and the continually improving treatment.
The most common type of breast cancer is invasive ductal carcinoma. It accounts for greater than 80% of all invasive breast cancers. There are other types of breast cancer, such as invasive lobular, which comprise about 10% of invasive breast cancers. Very early types of noninvasive breast cancer are known as ductal carcinoma in situ and lobular carcinoma in situ.
It is not known exactly what causes breast cancer, but some risk factors are known to be linked to the disease. One risk factor is aging. Women over age 50 have seen a rise in their risk of developing breast cancer. Also, there are possible genetic risk factors. Mutations in certain genes have been found to create a greater chance of developing breast cancer. Other risk factors include a family history, such as a blood relative diagnosed with this disease. If you have been diagnosed with breast cancer in the past, there is an increased risk of developing cancer in the remaining breast.
The following information is a comparison of Manatee Memorial Hospital (MMH) breast cancer cases with the National Cancer Data Base (NCDB). The NCDB was designed by the American Cancer Society and the American College of Surgeons. The NCDB is a format for accumulating standardized data on major and minor cancer sites from hospital cancer registries. The NCDB data used in this Cancer Report are taken from 2002 and 2003 statistics from more than 1300 hospitals in the United States. The NCDB data used for the five-year observed survivals are from 1998.
Frequency
During the year 2005 MMH registered 87 analytic cases of breast cancer. This represents a decrease of 19 cases from the previous year. This decrease probably is due to women being diagnosed in the outpatient setting more frequently.
Age and Gender
The NCDB data demonstrate that the greatest number of patients were diagnosed in the 70-79 age group. At MMH we have seen a younger age group with 22% of our patients diagnosed in the 50-59 age group. All analytic breast cancer patients seen at MMH in 2005 were women.
Click to view Age Which Breast Cancer
Patients Were Diagnosed chartStageThe stage at diagnosis is very important to the treatment plan. Staging is the process of finding out how the far the cancer has spread. The earlier the diagnosis is made the more favorable the prognosis. Staging in breast cancer is based on the size of the tumor and the extension of the tumor into surrounding tissues. Staging also considers whether the tumor has spread to organs distant from the breast. Stages are labeled using Roman numerals 0 through IV. The lower the number, the less the cancer has spread; the higher number, such as stage IV, means the cancer has spread to other organs. The NCDB reports Stage 0 was 15% of their total breast cancer cases. Stage I was diagnosed in 42%. Stage IV (cancer spread to other organs) in 3%. At MMH we demonstrate 29% diagnosed at stage 0 (very early noninvasive cancer), 32% at stage I and only 2% at stage IV. Click to view Stage Which Breast Cancer Patients Were Diagnosed chartTreatmentThe most common type of treatment for breast cancer is surgery. This may include procedures to remove the mass or lump, called a lumpectomy. Other possible surgical procedures include a partial mastectomy or a modified radical mastectomy. Also, the surgeon may offer a sentinel lymph node biopsy, which checks the initial or sentinel axillary lymph nodes that drain the breast fluids. Depending upon the stage and/or surgery, patients may be offered radiation therapy and/or chemotherapy and possibly hormone therapy. Click to view Four Most Frequent Breast Cancer Surgeries chart
SurvivalAs demonstrated below, MMH’s 5-year observed survival rates compare similarly to national statistics. There are several factors to keep in mind when reviewing survival statistics. The patients’ comorbid conditions (other illnesses) must be considered as well as the stage at the time the cancer was discovered. As demonstrated, our survival rates for Stage 0, 1 and 2 compare very favorably to national rates. Click to view Breast Cancer 5-Year Survival chart ConclusionsThis disease is most common among women, with only 1% of men diagnosed with breast cancer. The best preventative action a woman can undertake is practicing self breast examination and obtaining a regular mammogram after age 40. You are your own best defense against this treatable disease. If you have a mother or sister diagnosed with breast cancer, make sure your physician is aware of this, especially if a relative has been diagnosed recently.
What is a Cancer Registry?
The Cancer Registry is a data collection center for all cases of cancer diagnosed and treated at Manatee Memorial Hospital (MMH). The medical records of all oncology patients are analyzed by the Cancer Registrar to determine stage, treatment and survival. An important component of the Registry’s work is annual lifetime follow-up of former patients.
MMH’s Cancer Program is approved by the American College of Surgeons, Commission on Cancer. This means our cancer program has met stringent requirements in the care of our cancer patients. We perform annual patient-care evaluations, comparing our work with national statistics. We also assist in preparing MMH’s Cancer Management Conferences and Oncology Committee meetings. We are required to follow Florida State Law by reporting malignancies to the Florida Cancer Data System. In addition, we work with the American Cancer Society on various projects throughout the year.
The success of our cancer program would not be possible without the support of administration, the medical staff and ancillary departments. Special thanks go to our volunteers, Florence Barstow, Lorraine Holt and Donna Rose, who give unselfishly of their time each week.
Jamie Suarez, RHIT, CTR
Cancer Registrar
Accuracy of the Registry data contained in the 2005 Annual Report depends upon complete documentation in the medical record. If the treatment plan is not known upon discharge of the patient, the Cancer Registry contacts the appropriate physician's office to ascertain if the first course of treatment was given at another location. In some cases, patients initially refuse treatment or subsequently receive treatment after the first four months.
2006 Cancer Program Annual Report was produced by the Cancer Registry and the Marketing Department at Manatee Memorial.
2005-2006 Oncology Committee
Manatee Memorial's Cancer
Program is approved by the Commission on Cancer of the American College of Surgeons
Thomas Farrell, M.D.
Cancer Liaison Physician for Manatee Memorial
K. Telukuntla, M.D., Chairperson, Medical Oncology
T.J. Farrell, M.D., ACoS Liaison,
Pathology
A.S. Hassan, M.D., Surgery
C. H. Amar Inalsingh, M.D.,
Radiation Oncology
Y. Nadiminti, M.D., Medical Oncology
J. Pecoraro, M.D., Surgery
P. Ray, M.D., Radiation Oncology
M. Saunders, M.D., Pathology
L. Silverman, M.D., Radiation Oncology
J. Wasserman, D.O., Radiology
Non-Physician Members:T. Buchanan, RN Director,
P.I. & Risk Mgmt.
B. Chambliss, Director, Promotions & Community Relations
S. Drackett, Pharmacy
N. Dugas, RN, Manager, Outpatient Services
G. Fisher, D.Min, Chaplain
J. Hawkins, RN, Nurse Manager,
Oncology Department
B. Heinz, RHIA, Director,
Health Information Management
E. Honig, RN, OCN, Director,
Care Coordination
P.Jefferson, RN. Director, Imaging Services
C. Malloy, RN, Chief Nursing Officer
D. Mann, RN, Director, Medical/Surgical
J. Suarez, RHIT, CTR, Cancer Registry
Definition of Terms
American College of Surgeons – The ACoS, Commission on Cancer is referred to in this text in reference to breast cancer patient care evaluation. The ACoS is the organization that surveys and approves cancer programs.
Analytic – Pertains to those cases initially diagnosed and/or receiving their first course of treatment at Manatee Memorial Hospital.
Florida Cancer Data System – The FCDS is an incidence registry for the State of Florida. FCDS is a cancer registry administered by the Florida Department of Health and is operated and maintained by the Sylvester Comprehensive Cancer Center at the University of Miami School of Medicine.
Nonanalytic (N/A) - A case diagnosed and treated elsewhere prior to being seen at Manatee Memorial Hospital. Cases that were treated greater than four months after initial diagnosis. Cases that were initially diagnosed at autopsy are considered nonanalytic as well.
SEER – Surveillance, Epidemiology, End Results this program is a division of the National Cancer Institute. SEER publishes cancer incidence and survival data from 11 population-based registries.
Stage – The registry records stage using the AJCC (American Joint Committee on Cancer Manual) for staging guide. Stage 0, I, II, III, IV or Unknown.
Survival – The actuarial method of calculating survival provides a means for using all follow-up information accumulated up to the closing date of study.
Note: The information on this Web site is provided as general health guidelines and may not be applicable to your particular health condition. Your individual health status and any required medical treatments can only be properly addressed by a professional healthcare provider of your choice. Remember: There is no adequate substitution for a personal consultation with your physician. Neither Manatee Memorial Hospital, or any of their affiliates, nor any contributors shall have any liability for the content or any errors or omissions in the information provided by this Web site.
The information, content and artwork provided by this Web site is intended for non-commercial use by the reader. The reader is permitted to make one copy of the information displayed for his/her own non-commercial use. The making of additional copies is prohibited.
|
|
|
|
| |
|
Print Page
